BACKGROUND: Approximately half of the patients presenting with ST-segment-elevation myocardial infarction (STEMI) have multivessel disease. The physiology of the nonculprit artery has not been thoroughly studied to date. We sought to characterize the coronary physiology of the nonculprit artery in the early phase after STEMI and determine the real prevalence of microvascular and endothelial dysfunction.
I
n patients with ST-segment-elevation myocardial infarction (STEMI), prompt coronary revascularization of the culprit lesion improves prognosis and, thus, is the current clinical practice supported by guidelines. 1 However, approximately half of the patients with STEMI have multivessel disease, which is associated with worse outcomes. 1 Often, the decision to perform percutaneous coronary intervention of the nonculprit vessel is based on the angiographic appearance, ignoring the physiology of the artery. Recently, a revascularization strategy of the nonculprit artery using fractional flow reserve (FFR) has proven a safe and effective strategy in patients with STEMI. 2 However, this approach also obviates the possible presence of microvascular and endothelial dysfunction and their potential prognostic significance. Despite the current interest in the nonculprit artery, a comprehensive description of the epicardial, microvascular and endothelial function of its territory has not been performed to date. We aimed to characterize the whole coronary physiology of the nonculprit artery in the early phase after a STEMI and determine the real incidence of microvascular and endothelial dysfunction.
METHODS
Anonymized data will be made available by the corresponding author for reasonable requests. Consent was not obtained for data sharing, but the presented data are anonymized and risk of identification is minimal.
Study Population
The FISIOIAM (FISIOlogía del Infarto Agudo de Miocardio) is an observational, prospective, single-center study including patients with STEMI and multivessel disease. Candidates were patients 18-years of age or older who had had a STEMI with successful treatment of the culprit artery-defined as final TIMI (Thrombolysis in Myocardial Infarction) grade-3 flowand at least another lesion in a nonculprit territory with a stenosis severity over 40% by visual assessment. We excluded patients with critical coronary stenosis (>90% severity) to minimize unnecessary risks when the need for revascularization was clear. An increase in cardiac biomarkers was mandatory. All subjects were treated according to current guidelines. 1 The protocol was approved by the Institutional Review Board, and informed consent was obtained from all patients.
Invasive Physiological Characterization Protocol
The physiological study of the nonculprit artery took place in a second procedure after initial successful revascularization of the culprit artery. It was conducted in 3 phases ( Figure 1 ):
Phase 1. Macrovascular Endothelial Function
Once the nonculprit artery was engaged, a first angiography without previous nitroglycerin administration was performed. Then, acetylcholine was administered intracoronarily for assessment of the macrovascular endothelial response. Progressive doses of 2-20-100 µg were used in the left coronary artery, and 2-20-50 µg in the right coronary artery, administered slowly over 3 minutes. After each dose, an angiogram was performed. If significant vasoconstriction was observed at any point, no further doses were administered. Finally, an intracoronary bolus of 200 μg of nitroglycerin was given to revert the vasoconstriction and establish the vessel reference diameter. Macrovascular endothelial dysfunction was defined as any significant vasoconstriction (reduction ≥50% of the vessel diameter) in an epicardial coronary segment after acetylcholine infusion.
3

Phase 2. FFR, CFR, and EndotheliumIndependent Microvascular Function
Subsequently, an intracoronary pressure-temperature sensor-tipped guidewire (Certus PressureWire, StJude Medical, MN) was advanced beyond the lesion. Baseline and hyperemic coronary flows were measured using the thermodilution method. 4 Hyperemia was induced using intravenous perfusion of adenosine (140 μg/kg per minute) through a large brachial vein. FFR was calculated as the ratio of distal coronary pressure (Pd) to proximal pressure (Pa) during hyperemia. Coronary flow reserve (CFR) was calculated as the ratio of baseline mean transient time (Tmn) and hyperemic Tmn. 4 The index of microvascular resistance (IMR) was calculated as the product of Tmn and Pd during hyperemia. 5 To adjust for the imprecision inherent to collateral flow, we calculated the FFR-adjusted IMR. 6 Baseline resistance was also computed, as well as the ratio of IMR and baseline resistance, the resistive reserve ratio. 7 An abnormal CFR was considered as any value <2. 8 Endothelium-independent microvascular dysfunction was defined as an IMR over 25. 9 In line with current
WHAT IS KNOWN
• The identification of microvascular or endothelial dysfunction in patients with coronary artery disease has prognostic implications.
• Microvascular dysfunction in the infarct-related territory is common after revascularization. Safety concerns exist regarding acetylcholine administration in the early phase post-ST-segment-elevation myocardial infarction.
WHAT THE STUDY ADDS
• Microvascular and endothelial dysfunction in the nonculprit territory after myocardial infarction are very common. Globally, 93% of patients with myocardial infarction have functional abnormalities in the nonculprit territory.
• Acetylcholine administration in the acute phase post-ST-segment-elevation myocardial infarction is safe.
general practice, significant coronary stenosis was defined as an FFR≤0.8.
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Phase 3. Endothelium-Dependent Microvascular Function
Once the perfusion of adenosine was stopped, we waited at least 5 minutes and checked that the Tmn had returned to baseline values. Then, we recorded baseline pressure and Tmn and induced endothelium-dependent hyperemia using the maximal dose of acetylcholine tolerated at phase 1; immediately, we recorded the pressure and Tmn again. The endothelial components of the microvascular function are here described as the endothelial CFR 10 (eCFR), the endothelial IMR, and the endothelial resistive reserve ratio. An eCFR<1.5 was considered diagnostic of endothelial microvascular dysfunction. 11 Finally, percutaneous coronary intervention of the nonculprit artery stenosis was performed in patients with an FFR ≤0.8, according to current clinical practice. However, the final decision was left to the physician's discretion.
Variables, Definitions, and End Points
We recorded all relevant clinical and procedural data, the physiological invasive parameters described above, and longterm outcomes through medical record review and, when necessary, telephone follow-up. We defined a composite end point of major cardiovascular events that included mortality, myocardial infarction, and revascularization of the nonculprit artery. We did follow-up at 30 days, 6 months, and 1 year.
Statistical Analysis
Continuous variables are summarized as mean±SD unless otherwise noted, and were compared using Student t test or Mann-Whitney U test, as appropriate. Categorical variables are presented as frequency (%) and were compared using the χ 2 test. Normalcy and homogeneity of the variances were tested using the Kolmogorov-Smirnov and Levene tests. All P values are 2-tailed at a 0.05 significance level. Statistical analysis was performed with SPSS 20.0 (IBM Corp, Armonk, NY) and R v. 3.4.3.
RESULTS
Eighty-four patients with STEMI and multivessel disease were included between July 2016 and December 2017. Mean age was 62±10 years, and 87% were men. Baseline demographics and STEMI characteristics are summarized in Table 1 . Most patients were in Killip Class 1 and had a high prevalence of cardiovascular risk factors. Twelve patients (14%) did not meet strict ST elevation criteria but were included on the finding of a complete acute thrombotic occlusion of the culprit artery. Approximately half of the patients presented with an acute lesion in the right coronary artery. Almost all patients were treated with drug-eluting stents and through the radial artery. Mean left ventricular ejection fraction was 54±9%. Median time since hospital Upper row depicts a 59-y-old male who had had an inferior ST-segment-elevation myocardial infarction (STEMI). An intermediate stenosis was observed in the mid-left descending artery (LAD; A, arrow). Both macro and microvascular endothelium-dependent responses were abnormal: a severe diffuse vasoconstriction was observed in the mid-distal LAD after 20mcrg of acetylcholine (B), and endothelial coronary flow reserve (eCFR) was 1.2. However, endothelium-independent microvascular function was preserved, as CFR and index of microvascular resistance (IMR) were 4.5 and 13, respectively. Fractional flow reserve (FFR) was 0.8, and thus, a drug-eluting stent was implanted (C). Lower row shows a 78-y-old male who had had a lateral STEMI. A moderate stenosis was observed in the posterior interventricular artery (D, arrow). No macrovascular vasoconstriction was observed after acetylcholine (E and F), and eCFR was 2. On the contrary, endotheliumindependent microvascular dysfunction was evident: CFR was 1.7 and IMR 60. FFR was 0.89, and medical management was decided.
admission to the second procedure was 2 days (interquartile range, 2-4). However, in 17 subjects (20%) the protocol was performed after hospital discharge.
The endothelium-independent response after adenosine infusion was assessed in 83 patients; in one, the pressure-wire was occlusive, flow was deemed compromised, and percutaneous coronary intervention was immediately performed. The main results are shown in Table 2 . Mean quantitative coronary analysis lesion stenosis and length were 61±12% and 14±9 mm respectively. A functionally significant coronary artery stenosis according to FFR was observed in a third of the patients (33.7%). A low CFR was present in 31 (37.3%) patients, and an increased IMR in 23 (27.7%).
The endothelium-dependent macrovascular response was studied in all but 4 subjects, in whom there were safety concerns (2 had high risk of severe AV block; the other 2 had diffuse atherosclerotic disease).
The main results are shown in Table 3 . Macrovascular endothelial dysfunction was observed in 60% of the patients. Interestingly, when coronary vasoconstriction occurred, it affected the nonculprit plaque in 81% of the cases, and in 13 subjects, it occurred exclusively on the nonculprit plaque.
The endothelium-dependent microvascular study was performed in 73 patients. It was not performed in the 4 patients already mentioned who did not receive acetylcholine and in 7 additional patients who presented with occlusive vasoconstriction during the first phase. Endothelial microvascular dysfunction (eCFR<1.5) was present in 43.8% of the patients. Macrovascular and microvascular endothelial dysfunction showed no significant correlation (P=0.44). Patients BMI indicates body mass index; GRACE, Global Registry of Acute Coronary Events Score; HDL, high-density lipoprotein; HS-TnT, high-sensitivity T-troponin; IQR, interquartile range; LAD, left descending artery; LDL, lowdensity lipoprotein; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide; and RCA, right coronary artery. with endothelial microvascular dysfunction had also a lower endothelium-independent CFR (2.3±1.2 versus 2.9±1.4, P=0.043); however, linear correlation between eCFR and CFR was weak (R=0.22; see Figure 2 ). Globally, only 6 patients (7.1%) had a completely normal study, defined as a nonpathological FFR, IMR, CFR, macrovascular response to acetylcholine and eCFR. Figure 2 depicts the main correlations between microvascular and epicardial parameters. No significant differences in microvascular parameters were observed in patients according to sex or the presence of significant stenosis (Tables I and II in the Data Supplement) .
The only complications were 2 transient paroxysmal episodes of atrial fibrillation during the adenosine infusion. In-hospital mortality was 0%, and median hospital stay was 3 days (interquartile range, 2-4). Medical therapy included beta blockers (75%), angiotensin converting enzyme inhibitors/angiotensin receptor blockers (78%) and statins (100%). In the first 6 months, major cardiovascular events occurred in one patient (1.2%), who died because of spontaneous intracranial hemorrhage. At 1-year follow-up (n=41), no further major cardiovascular events occurred.
DISCUSSION
To the best of our knowledge, the FISIOIAM is the first study to date to perform a comprehensive analysis of the nonculprit artery physiology in the setting of a STEMI. We conducted the study to evaluate the endothelium-dependent and endothelium-independent response, both in the macro and microvascular compartments. This study has shown that it is feasible and safe to comprehensively investigate the physiology of the nonculprit artery shortly after a STEMI. The second important finding of the study is that most subjects presenting with STEMI and multivessel disease have an abnormal macrovascular or microvascular function.
Acetylcholine is frequently used, mainly patients with angina without obstructive coronary lesions, to help elucidate the cause of the chest pain. 12 Recently, it has been proposed as part of formal diagnostic protocols in patients with acute myocardial infarction and nonobstructive coronary artery disease. 13 However, acetylcholine has been barely used in the setting of STEMI, allegedly because of safety concerns. Previous data included patients in whom the study was postponed at least 30 days post-acute myocardial infarction 14, 15 or patients with nonST segment elevation acute coronary syndrome. 16 Significant coronary vasoconstriction was reported to take place in around 20% of patients, affecting predominantly the infarct-related territory. 15 In our study, we found a higher prevalence (60%) of epicardial vasoconstriction. It should be noted that, although a cutoff of 90% vasoconstriction is customary to diagnose Prinzmetal angina, our cutoff value for macrovascular endothelial dysfunction was 50%, which was recently associated with poor outcomes using the same administration protocol as ours. 3 The long-term persistence and clinical relevance of this endothelial dysfunction after STEMI is uncertain. We intend to study its evolution and its relationship with inflammation in an upcoming trial. 17 When analyzing the microvascular response to acetylcholine, 44% of the patients were not able to increase the coronary blood flow by 50%. It may be argued that some patients had epicardial vasoconstriction with the second acetylcholine administration, and thus, eCFR value might not be reflecting a purely microvascular effect. We think this is unlikely for 3 reasons: first, patients with a severe vasoconstriction during the first phase did not undergo the ulterior bolus; second, all patients received nitroglycerin before the third phase of the study, preventing the potential spasm; and third, because eCFR showed a very high correlation with endothelial resistive reserve ratio, which is a purely microvascular measurement.
We found a lower mean CFR in patients with endothelial microvascular dysfunction. We may attribute this to the coexistence of endothelium-dependent and independent microvascular dysfunction or to the fact that where there is structural damage to the microcirculation, the maximal hyperemia achieved with adenosine may be setting the ceiling, and the endothelial response to acetylcholine can go no further than that. Of note, CFR correlated poorly with FFR. This poor correlation between CFR and FFR has already been described in patients with stable coronary disease. 18 It underscores the unspecific-although prognostically relevant-information provided by CFR, especially in a population with mixed physiological alterations as this one, where CFR will capture the overall flow limitation but will not discriminate the particular mechanisms.
This is the first detailed study of the microcirculation in the nonculprit territory in the setting of STEMI and deserves special comment. First, in our study, with 86% of patients presenting with STEMI, IMR values of the nonculprit artery were similar to those reported in patients with nonSTEMI, 7 and only moderately higher than those reported in patients with angina in the absence of obstructive coronary disease. 19 Second, resistive reserve ratio-a specific measure of the vasodilatory capacity of the microcirculation-was higher than reported even in patients with stable angina. 7 All this suggests a certain degree of microvascular damage, but not a dramatic reduction in the vasodilation capacity of the nonculprit. The IMR has been validated as a predictor of left ventricular dysfunction, microvascular obstruction, and clinical outcomes. 9, [20] [21] [22] We studied differences in physiological parameters in 2 specific subgroups: women versus men, and vessels with ischemic versus nonischemic FFR (Tables I and II in  the Data Supplement) . Women showed no significant differences in microvascular and endothelial parameters compared with men. There was a nonsignificant trend towards a lower CFR, but IMR was equal between groups, which is consistent with previous findings in patients without obstructive coronary disease. 23 This discrepancy between CFR and IMR underscores the importance of microvascular resistance to specifically diagnose microvascular function.
We also found no significant differences in the endothelial and microvascular physiology between patients with ischemic and nonischemic FFR. In a previous study in stable patients, Echavarria-Pinto et al 18 found a higher CFR and IMR in arteries with FFR >0.8. We found a trend in the same direction, but it was not statistically significant, which may have been due to a smaller sample or to the fact that we are dealing with a different clinical context. We analyzed the Pd/Pa-FFR difference and its correlation with microvascular function to test the hypothesis that a limited hyperemia in this population may hinder the usefulness of FFR. We found no significant correlation in this aspect, which we think points to a good performance of FFR even in the presence of microvascular dysfunction.
Limitations
This is a small-sized study, unpowered to detect clinical events, and should be envisaged as hypothesis-generating. Although we made some subgroup comparisons, these should be taken with caution, given the small size of some groups.
We did not measure coronary wedge pressure for safety, but we estimated the FFR-adjusted IMR 8 and found insignificant differences with standard IMR. Also, the use of nitroglycerin may theoretically have affected the measurement of microvascular endothelial function. We decided to use this approach for 3 reasons: first, because it is generally accepted that nitroglycerin has no or minimal effect on the microcirculation; 24 second, to avoid risks for the patient; and third, because the basic assumption of constant macrovascular volume in thermodilution is violated in the presence of diffuse vasoconstriction. Finally, we did not perform intracoronary imaging, which may provide additional information about plaque instability and vulnerability.
Conclusions
Microvascular and endothelial dysfunction in the nonculprit artery territory in patients with STEMI are very common. In 93% of the patients, we found functional abnormalities. Acetylcholine administration in the early phase post-STEMI in patients with multivessel disease is safe.
